Collectively, our studies show that CD44 and CCR2 contribute to hepatitis in a model of NAFLD despite histological evidence of steatosis and elevated serological markers of hepatocellular damage. Here, CCR2 is linked to metabolic dysfunction-associated steatotic liver disease.